Antigen-binding fusion proteins with modified HSP70 domains Grant US-11718683-B2 United States of America 08 Aug 2023
Ex vivo antigen-presenting cells or activated CD-positive T cells for treatment of cancer Grant US-11364264-B2 United States of America 21 Jun 2022
HSP fusion protein with anti-chemorepellant agent for treatment of cancer Grant US-11325951-B2 United States of America 10 May 2022
HSP FUSION PROTEIN WITH ANTI-CHEMOREPELLANT AGENT FOR TREATMENT OF CANCER Application EP-3509609-A4 European Patent Office 20 Jan 2021